Exchange: NYSE·Updated 04:53 PM EDT
BHVN logo

BHVN Biohaven Pharmaceutical Holding Company Ltd

$14.19
$0.60
(4.41%)
Today
Closed $14.22
$0.03
(0.21%)
After Hours
EarningsNov 9
Mkt Cap$2.06B
Vol3.29M

About BHVN

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.
54

Neutral Sentiment

How do you feel about BHVN?

Advertisement|Remove ads.